2 not yet recruiting, 1 completed, 1 recruiting, 1 withdrawn. 2 Not applicable, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 2 |
| Phase 3 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow Lichen Sclerosus of Vulva: new trials by email Literature Review of Lichen Sclerosus of Vulva trials Research Report on Lichen Sclerosus of Vulva
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nemolizumab for LS Nemolizumab 30 mg - Lichen Sclerosus of Vulva | Phase 2 | Not yet recruiting | University of Texas Southwestern Medical Center | 25 | 2026-09-01 | 2026-07-15 |
| Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial Estradiol 0.01% Vag Cream, testosterone 0.1% and estradiol 0.01% vaginal cream - Vulvodynia, Dyspareunia | Phase 2 / Phase 3 | Not yet recruiting | TriHealth Inc. | 44 | 2025-12-01 | 2025-12-03 |
| VALOR: Vaginal Atrophy & Long-term Observation of Recovery 7-0940 - Atrophic Vaginitis, Vaginal Atrophy | Not applicable | Recruiting | Stratpharma AG | 2000 | 2023-10-30 | 2026-02-20 |
| Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva PRGF, Clobetasol Propionate - Lichen Sclerosus of Vulva | Phase 3 | Withdrawn | Fundación Eduardo Anitua | 2021-12-23 | 2025-02-27 | |
| Platelet Rich Plasma (PRP) for Vulvar Lichen Sclerosus Platelet Rich Plasma, Placebo - Lichen Sclerosus of Vulva | Not applicable | Completed | Center for Vulvovaginal Disorders | 29 | 2016-11-01 | 2018-10-25 |
Vulvar Lichen Sclerosus (5) · Lichen Sclerosus et Atrophicus (2) · Atrophic Vaginitis (1) · Dyspareunia (1) · Vulvodynia (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Urogenital Diseases (5) · Vulvar Diseases (5) · Lichenoid Eruptions (2) · Skin Diseases (2) · Skin Diseases, Papulosquamous (2) · Skin and Connective Tissue Diseases (2) · Genital Diseases, Male (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Sexual Dysfunction, Physiological (1) · Sexual Dysfunctions, Psychological (1)
Clobetasol (1) · Estradiol (1) · Testosterone (1) · Vaginal Creams, Foams, and Jellies (1) · nemolizumab (1)
Center for Vulvovaginal Disorders (1) · Fundación Eduardo Anitua (1) · Stratpharma AG (1) · TriHealth Inc. (1) · University of Texas Southwestern Medical Center (1)
United States (4)
Andrew T Goldstein, MD (1) · Melissa Mauskar, MD (1)